DTIL - Precision Biosciences Inc
IEX Last Trade
10.82
0.270 2.495%
Share volume: 63,847
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$10.55
0.27
2.56%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-08 | 2023-03-09 | 2023-05-09 | 2023-08-04 | 2023-11-07 | 2024-03-27 | 2024-05-13 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 271.733 M | 238.169 M | 204.502 M | 181.697 M | 164.344 M | 159.781 M | 184.741 M | 165.800 M | |
| Current Assets | 225.365 M | 199.105 M | 169.017 M | 147.864 M | 145.852 M | 136.359 M | 160.828 M | 144.035 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 12.599 M | 8.809 M | 10.191 M | 9.418 M | 20.111 M | 18.293 M | 22.294 M | 20.068 M | |
| Short Term Investments | 12.599 M | 8.809 M | 10.191 M | 9.418 M | 20.111 M | 18.293 M | 22.294 M | 20.068 M | |
| Total Receivables | 715.000 K | 720.000 K | 694.000 K | 652.000 K | 3.510 M | 901.000 K | 390.000 K | 207.000 K | |
| Current Cash | 212.051 M | 189.576 M | 158.132 M | 137.794 M | 122.231 M | 116.678 M | 137.766 M | 123.571 M | |
| Total Non-current Assets | 46.368 M | 39.064 M | 35.485 M | 33.833 M | 18.492 M | 23.422 M | 23.913 M | 21.765 M | |
| Property Plant Equipment | 21.791 M | 20.190 M | 18.591 M | 18.249 M | 8.739 M | 6.338 M | 5.286 M | 4.227 M | |
| Other Assets | 19.517 M | 12.778 M | 12.731 M | 12.225 M | 6.969 M | 13.478 M | 15.035 M | 13.957 M | |
| Intangible Assets | 1.969 M | 1.348 M | 1.525 M | 1.552 M | 977.000 K | 400.000 K | 386.000 K | 375.000 K | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 271.733 M | 238.169 M | 204.502 M | 181.697 M | 164.344 M | 159.781 M | 184.741 M | 165.800 M | |
| Total liabilities | 187.353 M | 177.736 M | 164.325 M | 147.656 M | 135.281 M | 140.920 M | 147.535 M | 91.086 M | |
| Total current liabilities | 61.148 M | 59.664 M | 46.859 M | 56.399 M | 50.617 M | 49.987 M | 33.338 M | 32.957 M | |
| Accounts Payable | 1.061 M | 1.225 M | 701.000 K | 781.000 K | 531.000 K | 2.968 M | 1.136 M | 1.144 M | |
| Other liabilities | 100.727 M | 93.073 M | 92.963 M | 88.084 M | 84.664 M | 83.082 M | 106.786 M | 51.038 M | |
| Current long term debt | 1.981 M | 2.037 M | 2.094 M | 24.816 M | 23.859 M | 23.545 M | 23.642 M | 23.717 M | |
| Long term debt | 25.478 M | 24.999 M | 24.503 M | 3.173 M | 0.000 | 7.723 M | 7.411 M | 7.091 M | |
| Other liabilities | 100.727 M | 93.073 M | 92.963 M | 88.084 M | 84.664 M | 83.082 M | 106.786 M | 51.038 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 84.380 M | 60.433 M | 40.177 M | 34.041 M | 29.063 M | 18.861 M | 37.206 M | 74.714 M | |
| Common stock | 110.849 M | 111.758 M | 111.301 M | 114.100 M | 115.175 M | 4.013 M | 5.061 M | 6.967 M | |
| Retained earnings | -399.824 M | -428.312 M | -453.372 M | -465.263 M | -473.342 M | -489.631 M | -481.043 M | -448.294 M |